Peritoneal Neoplasms: all 366 studies

Page 2 of 4. Open to participants first (56), then studies with results posted, then the rest; newest registration first within each.

• Allogeneic Natural Killer (NK) Cells for Ovarian, Fallopian Tube, Peritoneal and Metastatic Breast CancerCompletedNCT01105650Phase 2Results posted
• Alisertib (MLN8237) in Participants With Ovarian, Fallopian Tube or Peritoneal Cancer Preceded by Phase 1 Study of MLN8237 Plus Paclitaxel Treatment of Ovary or Breast CancerCompletedNCT01091428Phase 2Results posted
• LUME-Ovar 1: Nintedanib (BIBF 1120) or Placebo in Combination With Paclitaxel and Carboplatin in First Line Treatment of Ovarian CancerCompletedNCT01015118Phase 3Results posted
• Temsirolimus and Bevacizumab in Treating Patients With Advanced Endometrial, Ovarian, Liver, Carcinoid, or Islet Cell CancerCompletedNCT01010126Phase 2Results posted
• Paclitaxel and Carboplatin or Ifosfamide in Treating Patients With Newly Diagnosed, Persistent or Recurrent Uterine, Ovarian, Fallopian Tube, or Peritoneal Cavity CancerStatus unknownNCT00954174Phase 3Results posted
• OPT-821 With or Without Vaccine Therapy in Treating Patients With Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cancer in Second or Third Complete RemissionCompletedNCT00857545Phase 2Results posted
• Chemotherapy and Cetuximab in Patients Undergoing Surgery for Peritoneal Carcinomatosis From Colorectal CancerTerminatedNCT00766142Phase 2Results posted
• A Study of Carboplatin and DOXIL Plus Bevacizumab in Patients With Platinum Sensitive Recurrent Ovarian, Fallopian Tube and Primary Peritoneal CancersCompletedNCT00698451Phase 2Results posted
• Phase 1 Study of NY-ESO-1 Overlapping Peptides in Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00616941Phase 1Results posted
• Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube CancerCompletedNCT00569673Phase 2Results posted
• Autologous T Cells With or Without Cyclophosphamide and Fludarabine in Treating Patients With Recurrent or Persistent Advanced Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer (Fludarabine Treatment Closed as of 12/01/2009)CompletedNCT00562640Phase 1Results posted
• Avastin +/- Erlotinib Consolidation Chemotherapy After Carboplatin, Paclitaxel, and Avastin (CTA) Induction Therapy for Advanced Ovarian, Fallopian Tube, Primary Peritoneal Cancer & Papillary Serous or Clear Cell Mullerian TumorsCompletedNCT00520013Phase 2Results posted
• Avastin in Combination With Docetaxel in Ovarian/Fallopian Tube/Peritoneum CarcinomaCompletedNCT00504257Phase 2Results posted
• Trial of Pemetrexed and Carboplatin in Patients With Recurrent Ovarian or Primary Peritoneal CancerCompletedNCT00489359Phase 1/2Results posted
• Vandetanib to Treat Women With Ovarian, Fallopian Tube, or Primary Peritoneal CancerTerminatedNCT00445549Phase 2Results posted
• VEGF Trap and Docetaxel in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer, Primary Peritoneal Cancer, or Fallopian Tube CancerCompletedNCT00436501Phase 1/2Results posted
• Sorafenib and Bevacizumab to Treat Ovarian, Fallopian and Peritoneal CancerCompletedNCT00436215Phase 2Results posted
• Bevacizumab Study With Carboplatin & Paclitaxel in Ovarian, Fallopian Tube or Primary Peritoneal CancerTerminatedNCT00408070Phase 2Results posted
• Comparing Two Treatments for Ovarian Cancer: Standard Chemotherapy Plus Enzastaurin, or Placebo ("Sugar Pill")CompletedNCT00391118Phase 2Results posted
• Sunitinib Malate in Treating Patients With Recurrent Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT00388037Phase 2Results posted
• Docetaxel and Capecitabine in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Fallopian Tube Cancer, or Peritoneal Cavity CancerTerminatedNCT00354601Phase 2Results posted
• A Phase II Study of Surgical Debulking With Peritonectomy and Biweekly Intraperitoneal 5FU With Systemic Oxaliplatin/5FU/Leucovorin in Patients With Pseudomyxoma Peritonei or Peritoneal CarcinomatosisTerminatedNCT00352755Phase 2Results posted
• Octreotide Compared to Placebo in Patients With Inoperable Bowel Obstruction Due to Peritoneal CarcinomatosisCompletedNCT00332696Phase 2Results posted
• Carboplatin, Paclitaxel, and Surgery in Treating Patients With Advanced Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cavity CancerTerminatedNCT00331422Phase 2Results posted
• Effectiveness of MORAb-003 in Women With Ovarian Cancer Who Have Relapsed After Platinum-Based ChemotherapyCompletedNCT00318370Phase 2Results posted
• Topotecan and Gefitinib (Iressa) for Ovarian, Peritoneal, or Fallopian Tube CancerCompletedNCT00317772Phase 1/2Results posted
• Study of Gemcitabine/Carboplatin/Bevacizumab to Treat Ovarian, Fallopian Tube or Primary Peritoneal CancerCompletedNCT00267696Phase 2Results posted
• Carboplatin and Paclitaxel With or Without Bevacizumab in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Primary Peritoneal, or Fallopian Tube CancerCompletedNCT00262847Phase 3Results posted
• An Ovarian, Primary Peritoneal or Fallopian Tube Cancer Study for Patients That Have Not Received Prior ChemotherapyCompletedNCT00191646Phase 3Results posted
• Clinical Trial of Docetaxel in Combination With Gemcitabine in Platinum-Resistant Ovarian Cancer and Primary Peritoneal CarcinomaCompletedNCT00183794Phase 2Results posted
• Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube CancerStatus unknownNCT00108745Phase 3Results posted
• Gemcitabine Hydrochloride and Tanespimycin in Treating Patients With Recurrent Advanced Ovarian Epithelial or Peritoneal Cavity CancerCompletedNCT00093496Phase 2Results posted
• Cisplatin and Flavopiridol in Treating Patients With Advanced Ovarian Epithelial Cancer or Primary Peritoneal CancerCompletedNCT00083122Phase 2Results posted
• Debulking and Chemotherapy With or Without Intraperitoneal Chemotherapy to Treat Peritoneal CarcinomatosisCompletedNCT00052962Phase 3Results posted
• Treatment of Peritoneal Cancer With Surgery, Perfused Heated Cisplatin and ChemotherapyCompletedNCT00004547Phase 2Results posted
• Molecular Citology to Detect Free Cancer Cells in Peritoneal FluidCompletedNCT07478107
• Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab DeviceCompletedNCT06789224Not applicable
• Preoperative Inflammatory Markers Predict Postoperative Complications After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Peritoneal Colorectal CarcinomatosisCompletedNCT06318793
• Inferior Epigastric Lymp Node (IELN) Basin as a Possible Systemic Metastatic Pathway of Ovarian Peritoneal MetastasesCompletedNCT06237582Not applicable
• The PIPAC-OPC7 Study: The Use of PET/CT Scans as a Method of Evaluation in Patients Treated With PIPAC, a Pilot Study.CompletedNCT06144853
• A Study to Evaluate the Safety of KAND567, in Combination With Carboplatin Therapy, in Women With Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal CancerCompletedNCT06087289Phase 1/2
• Galunisertib Combined With Capecitabine in Advanced CRC With PMActive, not recruitingNCT05700656Phase 1/2
• Near-infrared Imaging With Indocyanine Green for Detection of Peritoneal Metastases for Gastric Adenocarcinoma.TerminatedNCT05687617Phase 2
• PIPAC and FOLFOX for Gastric Cancer Peritoneal CancerCompletedNCT05644249Not applicable
• Diagnostic Value of Diffusion-weighted Magnetic Resonance in High-risk Colorectal and Appendiceal NeoplasmsActive, not recruitingNCT05623787Not applicable
• AB-1015, an Integrated Circuit T (ICT) Cell Therapy in Patients With Platinum Resistant Epithelial Ovarian CancerActive, not recruitingNCT05617755Phase 1
• A Nomogram to Predict Major Postoperative Complications After Cytoreductive Surgery and HIPEC Based on Pre and Peroperative Criteria: Which Patient Require Intensive Monitoring?CompletedNCT05547568
• Intraperitoneal Chemotherapy in Gastric Cancer With Peritoneal CarcinomatosisStatus unknownNCT05541146Phase 2
• Concomitant Intraperitoneal and Systemic Chemotherapy in Patients With Extensive Peritoneal Carcinomatosis of Gastric OriginCompletedNCT05379790Phase 1
• ZN-c3 for the Treatment of Metastatic Triple-Negative Breast Cancer and Advanced Ovarian CancerWithdrawnNCT05368506Early Phase 1
• Diagnostic Value of DWI-MRI for Detection of Peritoneal Metastases in High-risk Pancreatic Ductal Adenocarcinoma.CompletedNCT05340569Not applicable
• Metachonous Peritoneal Carcinomatosis Incidence After Curative Surgery for pT4 Colon Cancer PatientsCompletedNCT05300789
• Intraperitoneal Aerosolized Nanoliposomal Irinotecan (Nal-IRI) in Peritoneal Carcinomatosis From Gastrointestinal CancerActive, not recruitingNCT05277766Phase 1
• A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsTerminatedNCT05194072Phase 1
• Intraperitoneal Paclitaxel-loaded TPM for Treatment of Peritoneal CarcinomatosisTerminatedNCT05159050Phase 1
• Psychological, Psychophysical and Epigenetic Determinants of Chronic Pain After Cytoreductive - Hyperthermic Intraoperative ChemotherapyCompletedNCT05083338
• Role of Magnetic Resonance Enterography for Predicting Peritoneal Cancer IndexStatus unknownNCT05063019Not applicable
• Trial of Surufatinib Combined With Toripalimab in the Treatment of Peritoneal Metastatic Carcinoma of Gastrointestinal or Primary Peritoneal CancerStatus unknownNCT05030246Phase 2
• Peritoneal Carcinomatosis Leveraging ctDNA Guided Treatment in GI Cancer Study (PERICLES Study)SuspendedNCT04929015Not applicable
• Study of Safety and Efficiency of the Use of Neutral Argon Plasma in Cyto-reduction of Miliary Implants in the Peritoneal Surface.CompletedNCT04904042Not applicable
• Feasibility Study of a 4 Stage Bowel Obstruction Cancer DietCompletedNCT04898842Not applicable
• Effect of the PIPAC on the Survival Rate of Patients With Peritoneal Carcinomatosis of Gastric OriginCompletedNCT04879953
• A Study of Oral Gimatecan in Platinum-Resistant Epithelial Ovarian, Fallopian Tube or Peritoneal CancerStatus unknownNCT04846842Phase 2
• Pasireotide to Reduce Clinically Relevant Digestive Leakage After Complete Cytoreductive Surgery (CRS) Plus Hyperthermic Intra-Peritoneal Chemotherapy (HIPEC) for Peritoneal CarcinomatosisTerminatedNCT04826432Phase 2
• A Phase II Study of Conversion Surgery After IP Paclitaxel With XELOX Chemotherapy in AGC With Peritoneal DisseminationStatus unknownNCT04797923Phase 2
• Preoperative Abdominal Enhanced CT, 18F-FDG PET/CT and 68Ga-FAPI PET/CT in Peritoneal Carcinomatosis of Gastric CancerStatus unknownNCT04778345Not applicable
• Bonds Between Circulating Tumoral ADN (ctDNA) and the Development of Peritoneal Carcinomatosis for Patients Under PIPACCompletedNCT04766502Not applicable
• Study of Sequential Systemic Therapy + Intraperitoneal Paclitaxel in Gastric/GEJ Peritoneal CarcinomatosisActive, not recruitingNCT04762953Phase 2
• Changes in Coagulation in Colorectal Cancer Patients Undergoing Surgical TreatmentCompletedNCT04744688
• Second Line Oxaliplatin Based Chemotherapy Alone Versus Oxaliplatin Based PIPAC and Chemotherapy in Colorectal Peritoneal Carcinomatosis : A Phase II Randomize Mutli-centric StudyStatus unknownNCT04734691Phase 2
• Intraperitoneal Docetaxel in Combination With mFOLFOX6 for Gastric Cancer Patients With Peritoneal CarcinomatosisTerminatedNCT04583488Phase 1
• Characterization of Biophysical Stromal Properties in Human Cancer: Towards Personalized Computational OncologyCompletedNCT04512209Not applicable
• Abexinostat, Palbociclib, and Fulvestrant for the Treatment of Breast or Gynecologic CancerWithdrawnNCT04498520Phase 1
• Oregovomab Plus Chemo in Newly Diagnosed Patients With Advanced Epithelial Ovarian Cancer Following Optimal Debulking SurgeryActive, not recruitingNCT04498117Phase 3
• Combined Neoadjuvant Systemic and PIPAC Therapy (NASPIT) for Patients With Colorectal Peritoneal Metastasis Eligible for CRS and HIPEC: A Prospective Phase II TrialStatus unknownNCT04475159Phase 2
• Intraoperative ICG Fluorescence Imaging for Peritoneal Carcinomatosis DetectionStatus unknownNCT04352894Not applicable
• Link of Interest and Training ModelCompletedNCT04341337
• Lactate and Complications in Cytoreduction Surgery for Peritoneal CarcinomatosisCompletedNCT04307654
• The Impact of Gut Microbiota in Anastomoses Insufficiency After Resection and Direct Anastomosis for Colorectal Cancer.CompletedNCT04252560
• Comparison of "Roll-over' Technique With Standard Abdominal Paracentesis in Suspected Peritoneal CarcinomatosisTerminatedNCT04232384Not applicable
• Dedicated MR Imaging vs Surgical Staging of Peritoneal Carcinomatosis in Colorectal CancerStatus unknownNCT04231175Not applicable
• Paclitaxel for the Treatment of Gastric or Gastroesophageal CancerActive, not recruitingNCT04220827Phase 1
• Intraperitoneal Oxaliplatin in Combo w IV mFOLFIRI for Peritoneal Carcinomatosis From Colorectal & Appendiceal CancerTerminatedNCT04158349Phase 1
• Defining Inflammation Related to Peritoneal Carcinomatosis in Women With Ovarian or Colon Cancer.CompletedNCT04122937
• A Phase I Study Evaluating SCB-313 for the Treatment of Subjects With Peritoneal CarcinomatosisTerminatedNCT04047771Phase 1
• A Clinical Study of Gimatecan in Advanced Ovarian Epithelial Cancer, Fallopian Tube Cancer or Primary Peritoneal CancerStatus unknownNCT04029909Phase 1
• PIPAC With Nab-paclitaxel and Cisplatin in Peritoneal CarcinomatosisActive, not recruitingNCT04000906Phase 1
• Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in Peritoneal Carcinomatosis From Ovarian Cancer (Cyto-chip 2)CompletedNCT03931304
• Modified Immune Cells (Autologous CAR T Cells) in Treating Patients with Advanced, Recurrent Platinum Resistant Ovarian, Fallopian Tube or Primary Peritoneal CancerActive, not recruitingNCT03907527Phase 1
• Web-Based Coping and Communication Skills Intervention in Improving Psychological Adaptation in Patients With Gynecological CancerWithdrawnNCT03902379Not applicable
• Treatment of Malignant Peritoneal Mesothelioma (MESOTIP)SuspendedNCT03875144Phase 2
• Feasibility of the LUM Imaging System for Peritoneal Surface MalignanciesCompletedNCT03834272Phase 1/2
• Peritoneal Carcinomatosis Extent Evaluation: Radiologic, Laparoscopic and Pathologic.Status unknownNCT03798132
• Role of the Peritoneal Microenvironment in the Pathogenesis and Spread of Colorectal CarcinomatosisCompletedNCT03777943
• Specialized Immune Cells (nCTLs) and a Vaccine (Alpha-type-1 Polarized Dendritic Cells) in Treating Patients With Stage II-IV Ovarian, Fallopian Tube, or Primary Peritoneal CancerWithdrawnNCT03735589Phase 1/2
• Study of Radspherin® in Recurrent Ovarian Cancer Subjects With Peritoneal CarcinomatosisCompletedNCT03732768Phase 1
• Multi-modality Imaging in Peritoneal Carcinomatosis of Colorectal OriginStatus unknownNCT03699332Phase 1/2
• Reduction Of Cycles of neOadjuvant Chemotherapy for Advanced Epithelial Ovarian, Fallopian and Primary Peritoneal CancerStatus unknownNCT03693248Phase 3
• CAR-T Intraperitoneal Infusions for CEA-Expressing Adenocarcinoma Peritoneal Metastases or Malignant Ascites (IPC)WithdrawnNCT03682744Phase 1
• Intraperitoneal Paclitaxel Plus Systemic mFOLFOX6CompletedNCT03618758Phase 1/2

← Peritoneal Neoplasms overview